Last Price
0.212
Today's Change
-0.056 (20.89%)
Day's Change
0.171 - 0.244
Trading Volume
42,885,117
Profile
CERO
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Christopher B. Ehrlich M.B.A. Mr. Christopher B. Ehrlich M.B.A.
Full Time Employees: 8 8
IPO Date: 2021-11-30 2021-11-30
CIK: 0001870404 0001870404
ISIN: US71902K1051 US71902K1051
Beta: -0.46 -0.46
Last Dividend: 0.00 0.00
Dcf Diff: 0.00 0.00
Dcf: 0.00 0.00
Description
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
2
CEO Morning Brief
US Ordered TSMC to Halt Shipments of Chips for AI to China — Reuters
3
CEO Morning Brief
Dogecoin Outperforms Bitcoin as Trump Spurs Crypto Speculation
4
CEO Morning Brief
5
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
